Review and progress of drug therapy for infantile hemangioma of skin and soft tissue
10.3760/cma.j.issn.1008-1372.2018.08.051
- VernacularTitle:皮肤软组织婴幼儿血管瘤药物治疗回顾及进展
- Author:
Shize LEI
1
;
Qingmei SHI
;
Xingfan CHEN
;
Shaorong LEI
Author Information
1. 中南大学冶金与环境学院环境工程系
- Keywords:
Hemangioma/DT;
Skin neoplasms/DT;
Infant;
Review
- From:
Journal of Chinese Physician
2018;20(8):1278-1280,封3
- CountryChina
- Language:Chinese
-
Abstract:
This article summarizes the pharmacological treatment of infantile hemangioma in soft tissue.We aim to review the literature and summarize the mechanisms,methods,efficiency and adverse reactions of beta blockers,glucocorticoids,bleomycin and imiquimott,and to analyze the rational options.Beta blockers,as oral and external use,have high efficiency and few side effects,and can be used as a first -line medication for infantile hemangiomas.Imiquimod external use and topical glucocorticoid and bleomycin injection have good efficacy and potential adverse reactions.They can be used as an alternative treatment for infantile hemangioma.